Halia (nama botani: Zingiber officinale Roscoe) merupakan sejen... - dofaq.co
Halia (nama botani: Zingiber officinale Roscoe) merupakan sejen...
wikipedia - 26 Mar 2023
Halia (nama botani: Zingiber officinale Roscoe) merupakan sejenis tumbuhan yang selalu digunakan sebagai rempah perasa dalam masakan. Tanaman ini dipercayai berasal dari Asia Tenggara Kepulauan dan dipercayai mula diusahakan oleh orang Austronesia, kemudian merebak penggunaannya ke India, China, Afrika Barat dan Caribbean.
Halia Therapeutics Announces $30M Series C Financing to Advance Novel Pipeline of Anti-Inflammatory Therapeutics
PR Newswire - 31 Jan 2024
Halia Therapeutics Announces $30M Series C Financing to Advance Novel Pipeline of Anti-Inflammatory Therapeutics ...
Halia Therapeutics begins trial of HT-6184 for pain management
Clinical Trials Arena - 16 Feb 2024
Halia Therapeutics begins trial of HT-6184 for pain management ...
Halia Therapeutics to Present at BIO-Europe Spring 2024 Conference
Yahoo Finance - 12 Mar 2024
Halia Therapeutics to Present at BIO-Europe Spring 2024 Conference ...
Halia plans two trials testing its anti-inflammatory lead candidate
Pharmaceutical Technology - 22 Aug 2023
Halia plans two trials testing its anti-inflammatory lead candidate ...
Actor "Good At Playing The Villain" Serves Shiok Teh Halia & Curry Puffs At Tiny Shop In Suntec
8 Days - 16 Aug 2023
Actor "Good At Playing The Villain" Serves Shiok Teh Halia & Curry Puffs At Tiny Shop In Suntec ...
Halia Therapeutics Announces Collaboration with Canary Speech to Leverage its Cutting Edge AI- Driven Speech ...
PR Newswire - 06 Feb 2024
Halia Therapeutics Announces Collaboration with Canary Speech to Leverage its Cutting Edge AI- Driven Speech ... ...
Halia Therapeutics to test HT-6184 in MDS patients for first time
Clinical Trials Arena - 08 Dec 2023
Halia Therapeutics to test HT-6184 in MDS patients for first time ...
Halia Therapeutics to Present at 2024 BIO CEO & Investor Conference
PR Newswire - 21 Feb 2024
Halia Therapeutics to Present at 2024 BIO CEO & Investor Conference ...
Halia Therapeutics Announces Positive Phase 1 Clinical Trial Results for HT-6184 at the 5th Inflammasome ...
PR Newswire - 29 Nov 2023
Halia Therapeutics Announces Positive Phase 1 Clinical Trial Results for HT-6184 at the 5th Inflammasome ... ...
Halia Therapeutics Dosed its First Patient in Phase 2a Clinical Trial of HT-6184, a First-in-Class NLRP3-Inhibitor, for ...
PR Newswire - 13 Dec 2023
Halia Therapeutics Dosed its First Patient in Phase 2a Clinical Trial of HT-6184, a First-in-Class NLRP3-Inhibitor, for ... ...
Halia Therapeutics to Present New Preclinical Data at the 65th American Society of Hematology (ASH) Annual Meeting ...
PR Newswire - 27 Nov 2023
Halia Therapeutics to Present New Preclinical Data at the 65th American Society of Hematology (ASH) Annual Meeting ... ...
Halia Therapeutics Initiates Phase II Clinical Trial to Evaluate Efficacy of HT-6184, a First-in-Class NEK7/NLRP3 ...
PR Newswire - 15 Feb 2024
Halia Therapeutics Initiates Phase II Clinical Trial to Evaluate Efficacy of HT-6184, a First-in-Class NEK7/NLRP3 ... ...
Halia Therapeutics Continued Support to Utah's Industry Community Recognized by First Place at the Utah Business ...
PR Newswire - 31 Oct 2023
Halia Therapeutics Continued Support to Utah's Industry Community Recognized by First Place at the Utah Business ... ...
Halia Therapeutics to Attend the 42nd JP Morgan Healthcare Conference and Present at Biotech Showcase in San ...
PR Newswire - 04 Jan 2024
Halia Therapeutics to Attend the 42nd JP Morgan Healthcare Conference and Present at Biotech Showcase in San ... ...
Halia Therapeutics Opens the Doors of its New Headquarters and Laboratory Facilities in Lehi, Utah
PR Newswire - 16 Aug 2023
Halia Therapeutics Opens the Doors of its New Headquarters and Laboratory Facilities in Lehi, Utah ...
Halia Therapeutics to Present at the 17th Annual Pain Therapeutics Summit
PR Newswire - 18 Oct 2023
Halia Therapeutics to Present at the 17th Annual Pain Therapeutics Summit ...
Halia Therapeutics to Present at the 5th Inflammasome Therapeutics Summit
PR Newswire - 20 Nov 2023
Halia Therapeutics to Present at the 5th Inflammasome Therapeutics Summit ...
Halia Therapeutics Appoints Former Amgen Scientists, Lisa Shamon, Ph.D., as Vice President of Regulatory Affairs and ...
PR Newswire - 16 Nov 2023
Halia Therapeutics Appoints Former Amgen Scientists, Lisa Shamon, Ph.D., as Vice President of Regulatory Affairs and ... ...
Halia Therapeutics to Present at the 13th World Gastroenterology, IBD & Hepatology Conference
PR Newswire - 15 Dec 2023
Halia Therapeutics to Present at the 13th World Gastroenterology, IBD & Hepatology Conference ...